ArticleJournal of pain research2026
The Effectiveness of Ultrasound-Guided Glucose Combined with Mecobalamin Neurolysis in Treating Patients with Refractory Painful Peripheral Neuropathy Using the DCEC Ultrasound Score: A Retrospective Study.
Article in Journal of pain research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to to evaluate the efficacy and safety of hydrodissection in refractory painful peripheral neuropathy over six months, and to explore whether the DCEC ultrasound scoring system predicts treatment response. Methods: The study included 57 patients diagnosed with intractable painful peripheral neuropathy confirmed by neuroelectrophysiology who visited the outpatient or inpatient departments of the Affiliated Hospital of Guizhou Medical University from March 2023 to June 2024. All patients underwent nerve ultrasound examination and were scored using the DCEC ultrasound scoring system, as well as neurological function assessments (including the Michigan Neuropathy Screening Tool, Toronto Clinical Scoring Scale, and Short-Form McGill Pain Questionnaire). All patients were divided into two groups: the first group consisted of 18 patients with diabetic painful peripheral neuropathy, and the second group consisted of 39 patients with non-diabetic painful peripheral neuropathy. The adverse reactions and complications of both groups after nerve hydrodissection treatment were recorded. The correlation between nerve ultrasound DCEC scores, Michigan and Toronto scores, and visual analog scale (VAS) and Short-Form McGill scores before and after treatment was analyzed. Results: The VAS scores and SF-MPQ scores of both patient groups showed significant improvement at 1, 2, 3, and 6 months after treatment compared to before treatment ( Conclusion: Ultrasound-guided nerve hydrodissection may provide pain relief for patients with intractable painful peripheral neuropathy and has good safety. Further controlled studies are needed to confirm its efficacy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.